CN111364124A - Production process of medical nano-fiber with sterilization and waterproof functions - Google Patents
Production process of medical nano-fiber with sterilization and waterproof functions Download PDFInfo
- Publication number
- CN111364124A CN111364124A CN201811587927.4A CN201811587927A CN111364124A CN 111364124 A CN111364124 A CN 111364124A CN 201811587927 A CN201811587927 A CN 201811587927A CN 111364124 A CN111364124 A CN 111364124A
- Authority
- CN
- China
- Prior art keywords
- parts
- stirring tank
- sterilization
- nano
- fiber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001954 sterilising effect Effects 0.000 title claims abstract description 42
- 239000002121 nanofiber Substances 0.000 title claims abstract description 34
- 238000004659 sterilization and disinfection Methods 0.000 title claims abstract description 22
- 238000004519 manufacturing process Methods 0.000 title abstract description 8
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 24
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000007788 liquid Substances 0.000 claims abstract description 16
- 239000006087 Silane Coupling Agent Substances 0.000 claims abstract description 15
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229920001661 Chitosan Polymers 0.000 claims abstract description 12
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000012153 distilled water Substances 0.000 claims abstract description 12
- 235000019253 formic acid Nutrition 0.000 claims abstract description 12
- 239000004408 titanium dioxide Substances 0.000 claims abstract description 12
- 229920000747 poly(lactic acid) Polymers 0.000 claims abstract description 9
- 239000004626 polylactic acid Substances 0.000 claims abstract description 9
- 238000003756 stirring Methods 0.000 claims description 48
- 238000000034 method Methods 0.000 claims description 20
- 230000008569 process Effects 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 13
- 238000009987 spinning Methods 0.000 claims description 9
- OXIKLRTYAYRAOE-CMDGGOBGSA-N (e)-3-(1-benzyl-3-pyridin-3-ylpyrazol-4-yl)prop-2-enoic acid Chemical group N1=C(C=2C=NC=CC=2)C(/C=C/C(=O)O)=CN1CC1=CC=CC=C1 OXIKLRTYAYRAOE-CMDGGOBGSA-N 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 claims description 4
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims description 3
- 235000003097 Artemisia absinthium Nutrition 0.000 claims description 3
- 240000001851 Artemisia dracunculus Species 0.000 claims description 3
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims description 3
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 3
- 241000218691 Cupressaceae Species 0.000 claims description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 3
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 3
- 239000001138 artemisia absinthium Substances 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 238000010041 electrostatic spinning Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 235000011477 liquorice Nutrition 0.000 claims description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 3
- 240000001949 Taraxacum officinale Species 0.000 claims 1
- 238000009941 weaving Methods 0.000 abstract description 6
- 241000222122 Candida albicans Species 0.000 abstract description 5
- 241000588724 Escherichia coli Species 0.000 abstract description 5
- 241000607142 Salmonella Species 0.000 abstract description 5
- 241000191967 Staphylococcus aureus Species 0.000 abstract description 5
- 229940095731 candida albicans Drugs 0.000 abstract description 5
- 231100000518 lethal Toxicity 0.000 abstract description 3
- 230000001665 lethal effect Effects 0.000 abstract description 3
- 231100000225 lethality Toxicity 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 239000004744 fabric Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 241000245665 Taraxacum Species 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- JCHMFMSWRWHRFI-HMMYKYKNSA-N ethyl (2e)-2-[(2,5-dichlorophenyl)hydrazinylidene]-2-(2,6-dimethylmorpholin-4-yl)acetate Chemical group C1C(C)OC(C)CN1/C(C(=O)OCC)=N/NC1=CC(Cl)=CC=C1Cl JCHMFMSWRWHRFI-HMMYKYKNSA-N 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000002759 woven fabric Substances 0.000 description 2
- 241000233866 Fungi Species 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003373 anti-fouling effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Classifications
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F8/00—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof
- D01F8/18—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from other substances
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F1/00—General methods for the manufacture of artificial filaments or the like
- D01F1/02—Addition of substances to the spinning solution or to the melt
- D01F1/10—Other agents for modifying properties
- D01F1/103—Agents inhibiting growth of microorganisms
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F8/00—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof
- D01F8/04—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers
- D01F8/14—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers with at least one polyester as constituent
Abstract
The invention discloses a medical nanofiber with sterilization and waterproof functions, which comprises the following components in parts by weight: 60-70 parts of chitosan, 25-30 parts of polylactic acid, 20-25 parts of titanium dioxide, 10-15 parts of nano silver, 30-40 parts of sterilizing liquid, 10-14 parts of formic acid, 10-12 parts of distilled water and 2-5 parts of silane coupling agent. According to the production process of the medical nano-fiber with the sterilization and waterproof functions, the bacteria attached to the nano-fiber woven product in a lethal way by using the traditional Chinese medicines are harmless to human bodies and accord with medical standards, meanwhile, the woven product is formed by weaving the nano-fiber, water cannot be attached to the woven product and can be easily shaken off, and the lethality rate of escherichia coli, staphylococcus aureus, candida albicans and salmonella attached to the woven surface is high.
Description
Technical Field
The invention relates to the technical field of nano fibers, in particular to a production process of medical nano fibers with sterilization and waterproof functions.
Background
The application of the nano-fiber is very wide, for example, the nano-fiber is implanted into the surface of the fabric to form a layer of stable gas film, so that the amphiphobic interface fabric is prepared, and the fabric can be waterproof, oil-proof and antifouling; the fabric of the high-grade protective clothing made of the nano-fiber is porous and provided with a film, so that the high-grade protective clothing not only can enable air to permeate and has breathability, but also can block wind and filter fine particles, has barrier property to aerosol, and can prevent biochemical weapons and toxic substances.
Although the nanofiber has extremely excellent capacity, the nanofiber does not have a sterilization function, so that bacteria are easily bred in the use process of the compact nanofiber, the use effect is influenced, infection is easily caused, and the health of a patient is influenced.
Disclosure of Invention
Technical problem to be solved
Aiming at the defects of the prior art, the invention provides a production process of medical nano-fiber with sterilization and waterproof functions, which solves the problems mentioned in the background technology.
(II) technical scheme
In order to achieve the purpose, the invention provides the following technical scheme: a medical nanofiber with sterilization and waterproof functions comprises the following components in parts by weight: 60-70 parts of chitosan, 25-30 parts of polylactic acid, 20-25 parts of titanium dioxide, 10-15 parts of nano silver, 30-40 parts of sterilizing liquid, 10-14 parts of formic acid, 10-12 parts of distilled water and 2-5 parts of silane coupling agent.
Specifically, the composition comprises the following components in parts by weight: 62 parts of chitosan, 21 parts of polylactic acid, 25 parts of titanium dioxide, 15 parts of nano-silver, 31 parts of sterilizing liquid, 11 parts of formic acid, 11 parts of distilled water and 2 parts of silane coupling agent.
Specifically, the silane coupling agent comprises KH550 and KH 560.
A production process of medical nano-fiber with sterilization and waterproof functions comprises the following steps:
1) and preparing the sterilizing liquid: adding 30 parts of wormwood, 20 parts of golden cypress, 20 parts of liquorice, 15 parts of dandelion and the balance of distilled water into a traditional Chinese medicine extraction tank, decocting for 1-2h, filtering, taking out filter residues, and concentrating the obtained sterilizing liquid into clear paste to obtain the sterilizing liquid.
2) Adding the silane coupling agent, titanium dioxide and nano silver into the first stirring tank, starting the stirring tank, and stirring for 30-40min at the temperature of 60-80 ℃ to obtain a mixture A.
3) Adding chitosan into a second stirring tank, adding 1.5mol/L formic acid solution into the second stirring tank, starting the second stirring tank, and stirring at room temperature (25-30 ℃) for 1-2 hours to obtain a mixture B.
4) Taking out the mixture A in the first stirring tank, adding the mixture A into a second stirring tank, adding the sterilizing solution, starting the second stirring tank again, heating to 40-50 ℃, and stirring for 40-60min to obtain a spinning solution.
5) And adding the spinning solution into an ejector, and spinning by adopting a high-voltage electrostatic spinning technology.
Specifically, in the step 2), the rotation speed of the first stirring tank is 150-.
Specifically, in the step 3), the rotation speed of the second stirring tank is 100-120 r/min.
Specifically, in the step 4), the rotation speed of the second stirring tank is 200-240 r/min.
(III) advantageous effects
The invention provides a production process of medical nano-fiber with sterilization and waterproof functions, which has the following beneficial effects:
the fungi attached to the nanofiber woven product in a lethal mode through the traditional Chinese medicines are harmless to a human body and accord with medical standards, meanwhile, the woven product is formed by weaving the nanofibers, water cannot be attached to the woven product and can be shaken off easily, and the lethal rate of escherichia coli, staphylococcus aureus, candida albicans and salmonella attached to the woven surface is high.
Detailed Description
All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
The invention provides a technical scheme that: a medical nanofiber with sterilization and waterproof functions comprises the following components in parts by weight: 62 parts of chitosan, 21 parts of polylactic acid, 25 parts of titanium dioxide, 15 parts of nano-silver, 31 parts of sterilizing liquid, 11 parts of formic acid, 11 parts of distilled water and 2 parts of silane coupling agent.
Specifically, the silane coupling agent includes KH550 and KH 560.
A production process of medical nano-fiber with sterilization and waterproof functions comprises the following steps:
1) and preparing the sterilizing liquid: adding 30 parts of wormwood, 20 parts of golden cypress, 20 parts of liquorice, 15 parts of dandelion and the balance of distilled water into a traditional Chinese medicine extraction tank, decocting for 1-2h, filtering, taking out filter residues, and concentrating the obtained sterilizing solution into clear paste.
2) Adding the silane coupling agent, titanium dioxide and nano silver into the first stirring tank, starting the stirring tank, and stirring for 30-40min at the temperature of 60-80 ℃ to obtain a mixture A.
3) Adding chitosan into a second stirring tank, adding 1.5mol/L formic acid solution into the second stirring tank, starting the second stirring tank, and stirring at room temperature (25-30 ℃) for 1-2 hours to obtain a mixture B.
4) Taking out the mixture A in the first stirring tank, adding the mixture A into a second stirring tank, adding the sterilizing solution, starting the second stirring tank again, heating to 40-50 ℃, and stirring for 40-60min to obtain a spinning solution.
5) And adding the spinning solution into an ejector, and spinning by adopting a high-voltage electrostatic spinning technology.
Example 2
The process for producing medical nano-fiber with sterilization and waterproof functions as described in example 1 can further adopt the following processes:
comprises the following components in parts by weight: 65 parts of chitosan, 30 parts of polylactic acid, 22 parts of titanium dioxide, 114 parts of nano-silver, 38 parts of sterilizing liquid, 13 parts of formic acid, 12 parts of distilled water and 4 parts of silane coupling agent.
In the step 2), the rotating speed of the first stirring tank is 150 r/min.
In the step 3), the rotating speed of the second stirring tank is 100 r/min.
In the step 4), the rotating speed of the second stirring tank is 240 r/min.
Example 3
The process for producing medical nano-fiber with sterilization and waterproof functions as described in example 1 can further adopt the following processes:
comprises the following components in parts by weight: 70 parts of chitosan, 25 parts of polylactic acid, 22 parts of titanium dioxide, 11 parts of nano silver, 30 parts of sterilizing liquid, 11 parts of formic acid, 10 parts of distilled water and 2 parts of silane coupling agent.
In the step 2), the rotating speed of the first stirring tank is 180 r/min.
In the step 3), the rotating speed of the second stirring tank is 110 r/min.
In the step 4), the rotating speed of the second stirring tank is 220 r/min.
Example 4
The process for producing medical nano-fiber with sterilization and waterproof functions as described in example 1 can further adopt the following processes:
comprises the following components in parts by weight: 60 parts of chitosan, 30 parts of polylactic acid, 25 parts of titanium dioxide, 15 parts of nano-silver, 30 parts of sterilizing liquid, 14 parts of formic acid, 12 parts of distilled water and 5 parts of silane coupling agent.
In the step 2), the rotating speed of the first stirring tank is 190 r/min.
In the step 3), the rotating speed of the second stirring tank is 115 r/min.
In the step 4), the rotating speed of the second stirring tank is 225 r/min.
Weaving and experiment:
the nano-fiber prepared by using the chemical fiber filament weft is used as the warp, and the weaving distribution of the warp and the weft is woven by adopting one-up-one-down or two-up-two-down weaving to obtain the woven product.
The water solution containing the escherichia coli, the staphylococcus aureus, the candida albicans and the salmonella is dripped on the woven fabric, then the water droplets are shaken off, the lethality of the escherichia coli, the staphylococcus aureus, the candida albicans and the salmonella is more than 98% observed under a microscope, meanwhile, the woven fabric is formed by weaving the nano fibers, water cannot be attached, the shake-off can be easily caused, and the lethality of the escherichia coli, the staphylococcus aureus, the candida albicans and the salmonella attached to the woven surface is high.
It should be noted that, in this document, terms such as "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (7)
1. A medical nanofiber with sterilization and waterproof functions is characterized in that: comprises the following components in parts by weight: 60-70 parts of chitosan, 25-30 parts of polylactic acid, 20-25 parts of titanium dioxide, 10-15 parts of nano silver, 30-40 parts of sterilizing liquid, 10-14 parts of formic acid, 10-12 parts of distilled water and 2-5 parts of silane coupling agent.
2. The medical nanofiber with the sterilization and waterproof functions as claimed in claim 1, wherein: comprises the following components in parts by weight: 62 parts of chitosan, 21 parts of polylactic acid, 25 parts of titanium dioxide, 15 parts of nano-silver, 31 parts of sterilizing liquid, 11 parts of formic acid, 11 parts of distilled water and 2 parts of silane coupling agent.
3. The medical nanofiber with the sterilization and waterproof functions as claimed in claim 1, wherein: the silane coupling agent comprises KH550 and KH 560.
4. The process for producing medical nano-fiber with sterilization and waterproof functions as claimed in claim 1, wherein the process comprises the following steps: the method comprises the following steps:
1) and preparing the sterilizing liquid: adding 30 parts of wormwood, 20 parts of golden cypress, 20 parts of liquorice, 15 parts of dandelion and the balance of distilled water into a traditional Chinese medicine extraction tank, decocting for 1-2 hours, filtering, taking out filter residues, and concentrating the obtained sterilizing liquid into clear paste to obtain sterilizing liquid;
2) adding a silane coupling agent, titanium dioxide and nano silver into the first stirring tank, starting the first stirring tank, and stirring for 30-40min at the temperature rise value of 60-80 ℃ to obtain a mixture A;
3) adding chitosan into a second stirring tank, adding 1.5mol/L formic acid solution into the second stirring tank, starting the second stirring tank, and stirring at room temperature (25-30 ℃) for 1-2 hours to obtain a mixture B;
4) taking out the mixture A in the first stirring tank, adding the mixture A into a second stirring tank, adding the sterilizing solution, starting the second stirring tank again, heating to 40-50 ℃, and stirring for 40-60min to obtain a spinning solution;
5) and adding the spinning solution into an ejector, and spinning by adopting a high-voltage electrostatic spinning technology.
5. The process for producing medical nano-fiber with sterilization and waterproof functions as claimed in claim 1, wherein the process comprises the following steps: in the step 2), the rotation speed of the first stirring tank is 150-.
6. The process for producing medical nano-fiber with sterilization and waterproof functions as claimed in claim 1, wherein the process comprises the following steps: in the step 3), the rotation speed of the second stirring tank is 100-120 r/min.
7. The process for producing medical nano-fiber with sterilization and waterproof functions as claimed in claim 1, wherein the process comprises the following steps: in the step 4), the rotation speed of the second stirring tank is 200-240 r/min.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811587927.4A CN111364124A (en) | 2018-12-25 | 2018-12-25 | Production process of medical nano-fiber with sterilization and waterproof functions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811587927.4A CN111364124A (en) | 2018-12-25 | 2018-12-25 | Production process of medical nano-fiber with sterilization and waterproof functions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111364124A true CN111364124A (en) | 2020-07-03 |
Family
ID=71203942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811587927.4A Pending CN111364124A (en) | 2018-12-25 | 2018-12-25 | Production process of medical nano-fiber with sterilization and waterproof functions |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111364124A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112369742A (en) * | 2020-11-27 | 2021-02-19 | 南通嘉得利安全用品有限公司 | Antibacterial and antiviral gloves and production process thereof |
| CN112501763A (en) * | 2020-11-25 | 2021-03-16 | 武汉猫人云商科技有限公司 | Antibacterial thermal underwear and production process thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000314035A (en) * | 1999-04-28 | 2000-11-14 | Mitsubishi Rayon Co Ltd | Antimicrobial textile product |
| WO2008062775A1 (en) * | 2006-11-22 | 2008-05-29 | Nisshinbo Industries, Inc. | Resin composition for antibacterial and deodorant article and antibacterial and deodorant fiber and nonwoven fabric obtained from the same |
| CN106835343A (en) * | 2017-01-10 | 2017-06-13 | 中科纺织研究院（青岛）有限公司 | A kind of plants antimicrobial cellulose fibre and preparation method thereof and the medical water proof nonwoven cloth prepared using the fiber |
| CN108468098A (en) * | 2018-03-28 | 2018-08-31 | 常州普嘉服饰科技股份有限公司 | Antibacterial textile fabric, antibacterial textile fabric and antibacterial textile fabric preparation method |
| CN108505143A (en) * | 2018-04-10 | 2018-09-07 | 郑州智锦电子科技有限公司 | A kind of nanofiber and preparation method thereof |
-
2018
- 2018-12-25 CN CN201811587927.4A patent/CN111364124A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000314035A (en) * | 1999-04-28 | 2000-11-14 | Mitsubishi Rayon Co Ltd | Antimicrobial textile product |
| WO2008062775A1 (en) * | 2006-11-22 | 2008-05-29 | Nisshinbo Industries, Inc. | Resin composition for antibacterial and deodorant article and antibacterial and deodorant fiber and nonwoven fabric obtained from the same |
| CN106835343A (en) * | 2017-01-10 | 2017-06-13 | 中科纺织研究院（青岛）有限公司 | A kind of plants antimicrobial cellulose fibre and preparation method thereof and the medical water proof nonwoven cloth prepared using the fiber |
| CN108468098A (en) * | 2018-03-28 | 2018-08-31 | 常州普嘉服饰科技股份有限公司 | Antibacterial textile fabric, antibacterial textile fabric and antibacterial textile fabric preparation method |
| CN108505143A (en) * | 2018-04-10 | 2018-09-07 | 郑州智锦电子科技有限公司 | A kind of nanofiber and preparation method thereof |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112501763A (en) * | 2020-11-25 | 2021-03-16 | 武汉猫人云商科技有限公司 | Antibacterial thermal underwear and production process thereof |
| CN112369742A (en) * | 2020-11-27 | 2021-02-19 | 南通嘉得利安全用品有限公司 | Antibacterial and antiviral gloves and production process thereof |
| CN112369742B (en) * | 2020-11-27 | 2023-03-10 | 南通嘉得利安全用品有限公司 | Antibacterial and antiviral gloves and production process thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Maliszewska et al. | Electrospun polymer nanofibers with antimicrobial activity | |
| Wróblewska-Krepsztul et al. | Biopolymers for biomedical and pharmaceutical applications: Recent advances and overview of alginate electrospinning | |
| Fadil et al. | Review on electrospun nanofiber-applied products | |
| CN101187089A (en) | Silk fibroin and polyvinyl alcohol blending antibacterial nanometer fiber and its preparation method | |
| Gough et al. | Protein and polysaccharide-based fiber materials generated from ionic liquids: A review | |
| CN103572507A (en) | Preparation method for antibiosis ultraviolet prevention silk fibroin nanofiber membrane | |
| CN111364124A (en) | Production process of medical nano-fiber with sterilization and waterproof functions | |
| WO2008049251B1 (en) | Microbicidal nano- and meso-polymer fibers produced from polymers and honey, for textile applications | |
| CN103147310B (en) | Method for finishing cotton fabrics through spraying plant essential oil | |
| Rezaee et al. | Single-step synthesis and characterization of Zr-MOF onto wool fabric: Preparation of antibacterial wound dressing with high absorption capacity | |
| Leonés et al. | Potential applications of magnesium-based polymeric nanocomposites obtained by electrospinning technique | |
| DE102007026043B4 (en) | Non-toxic polyethoxysiloxane material for the manufacture of bioabsorbable and / or bioactive polyethoxysiloxane material containing articles, its preparation and use | |
| Pereao et al. | Chitosan/PEO nanofibers electrospun on metallized track-etched membranes: fabrication and characterization | |
| CN111440346B (en) | Antibacterial layer of nano silver wire and antibacterial mask of nano silver wire | |
| Ahmed et al. | Alleviating the toxicity concerns of antibacterial cinnamon‐polycaprolactone biomaterials for healthcare‐related biomedical applications | |
| Huesca-Urióstegui et al. | Nanofiber systems as herbal bioactive compounds carriers: Current applications in healthcare | |
| Han et al. | Electrospun grape seed polyphenols/gelatin composite fibers contained silver nanoparticles as biomaterials | |
| CN109252245B (en) | Super-absorbent alginate fiber and preparation method thereof | |
| CN102294052A (en) | Preparation method of medical high polymer based silver nano material | |
| CN105755673A (en) | Manufacturing method for antibacterial high selectivity nanofiber membrane | |
| Ajith et al. | Recent developments in electrospun nanofibers as delivery of phytoconstituents for wound healing | |
| CN108434528A (en) | A kind of intensifying method of chitosan electrostatic spinning composite nerve conduit | |
| WO2023163309A1 (en) | Method for preparing water-soluble chitosan fibers and method for manufacturing chitosan nonwoven fabric by using same | |
| Mejía et al. | Poly (vinyl alcohol)/Silk Fibroin/Ag NPs composite nanofibers for bone tissue engineering | |
| CN113005633A (en) | Antibacterial nanofiber membrane and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200703 |
|
| RJ01 | Rejection of invention patent application after publication |